164 related articles for article (PubMed ID: 31416738)
21. Dual aromatase-steroid sulfatase inhibitors.
Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
[TBL] [Abstract][Full Text] [Related]
22. Novel 1,2,3-Triazole Derivatives as Mimics of Steroidal System-Synthesis, Crystal Structures Determination, Hirshfeld Surfaces Analysis and Molecular Docking.
Daśko M; Dołęga A; Siedzielnik M; Biernacki K; Ciupak O; Rachon J; Demkowicz S
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279404
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
[TBL] [Abstract][Full Text] [Related]
24. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.
Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958
[TBL] [Abstract][Full Text] [Related]
25. Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
Singh Y; Jaswal S; Singh S; Verma SK; Thareja S
J Biomol Struct Dyn; 2023 Dec; 41(20):10604-10626. PubMed ID: 36510679
[TBL] [Abstract][Full Text] [Related]
26. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives.
Song Z; Liu Y; Dai Z; Liu W; Zhao K; Zhang T; Hu Y; Zhang X; Dai Y
Bioorg Med Chem; 2016 Oct; 24(19):4723-4730. PubMed ID: 27567077
[TBL] [Abstract][Full Text] [Related]
28. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Nagar S; Saha A
Eur J Med Chem; 2010 Sep; 45(9):4307-15. PubMed ID: 20638757
[TBL] [Abstract][Full Text] [Related]
29. Exploring new chemical functionalities to improve aromatase inhibition of steroids.
Varela CL; Amaral C; Correia-da-Silva G; Costa SC; Carvalho RA; Costa G; Alcaro S; Teixeira NA; Tavares-da-Silva EJ; Roleira FM
Bioorg Med Chem; 2016 Jun; 24(12):2823-31. PubMed ID: 27160054
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.
Wang R; Shi HF; Zhao JF; He YP; Zhang HB; Liu JP
Bioorg Med Chem Lett; 2013 Mar; 23(6):1760-2. PubMed ID: 23403081
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
Bubert C; Woo LW; Sutcliffe OB; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2008 Nov; 3(11):1708-30. PubMed ID: 18816537
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation, and molecular docking studies of new pyrazol-3-one derivatives with aromatase inhibition activities.
Yi XJ; El-Idreesy TT; Eldebss TM; Farag AM; Abdulla MM; Hassan SA; Mabkhot YN
Chem Biol Drug Des; 2016 Dec; 88(6):832-843. PubMed ID: 27565954
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
34. Insight into the enzyme-inhibitor interactions of the first experimentally determined human aromatase.
Punetha A; Shanmugam K; Sundar D
J Biomol Struct Dyn; 2011 Apr; 28(5):759-71. PubMed ID: 21294587
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis and Biological Evaluation of Aromatase Inhibitors Based on Sulfonates and Sulfonamides of Resveratrol.
Fantacuzzi M; Gallorini M; Gambacorta N; Ammazzalorso A; Aturki Z; Balaha M; Carradori S; Giampietro L; Maccallini C; Cataldi A; Nicolotti O; Amoroso R; De Filippis B
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681208
[TBL] [Abstract][Full Text] [Related]
36. Structure-based design of potent aromatase inhibitors by high-throughput docking.
Caporuscio F; Rastelli G; Imbriano C; Del Rio A
J Med Chem; 2011 Jun; 54(12):4006-17. PubMed ID: 21604760
[TBL] [Abstract][Full Text] [Related]
37. Discovery of new erbB4 inhibitors: Repositioning an orphan chemical library by inverse virtual screening.
Giordano A; Forte G; Massimo L; Riccio R; Bifulco G; Di Micco S
Eur J Med Chem; 2018 May; 152():253-263. PubMed ID: 29730188
[TBL] [Abstract][Full Text] [Related]
38. Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors.
Banjare L; Singh Y; Verma SK; Singh AK; Kumar P; Kumar S; Jain AK; Thareja S
J Biomol Struct Dyn; 2023 Mar; 41(4):1322-1341. PubMed ID: 34963408
[TBL] [Abstract][Full Text] [Related]
39. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and screening of aromatase inhibitory activity of substituted C19 steroidal 17-oxime analogs.
Pokhrel M; Ma E
Molecules; 2011 Nov; 16(12):9868-85. PubMed ID: 22124202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
